Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flu-Bu-Mel vs Flu-Bu Conditioning in AML/MDS
NCT05991908Phase 3Recruiting
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Oct 2023
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melphalan in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), sponsored by Shanghai Jiao Tong University School of Medicine. Started Oct 2023; status: recruiting.
02
Drugs
melphalan
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT05991908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05991908.